Epicareer Might not Working Properly
Learn More
Back

ASLAN Pharmaceuticals Limited

About the Company

ASLAN Pharmaceuticals Limited is a clinical-stage biopharmaceutical company that focuses on developing immunotherapies and targeted agents for Asia prevalent tumour types. It was founded in Singapore in 2011 and has since expanded its operations to Taiwan, China, and the United States. The company's lead candidate is ASLAN004, an IL-13Rα1 monoclonal antibody that is in Phase 2b clinical trials for atopic dermatitis. ASLAN Pharmaceuticals Limited also has a pipeline of other candidates, including ASLAN003, which is being developed for acute myeloid leukemia and ASLAN005, being developed for gastric cancer. The company has collaborations with various academic and industry partners to advance its drug development programs.

Industry Type

According to the GICS (Global Industry Classification Standard) version of March 2023, ASLAN Pharmaceuticals Limited’s industry classification falls within the following categories:
  • Sector: Health Care
  • Industry group: Pharmaceuticals, Biotechnology & Life Sciences
  • Industry: Life Sciences Tools & Services
  • Sub-Industry: Life Sciences Tools & Services
Videos and Photos

Company Address

3 Temasek Avenue, Level 18, Singapore 039190

Source : Google maps